Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists

被引:14
|
作者
Pettersson, Martin [1 ]
Campbell, Brian M. [1 ]
Dounay, Amy B. [1 ]
Gray, David L. [1 ]
Xie, Longfei [1 ]
O'Donnell, Christopher J. [1 ]
Stratman, Nancy C. [1 ]
Zoski, Kim [1 ]
Drummond, Elena [1 ]
Bora, Gary [1 ]
Probert, Al [1 ]
Whisman, Tammy [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
关键词
Norepinephrine reuptake inhibitor; 5-HT1A agonist; NRI; NET; DAT; SERT; ADHD; Depression; EFFICACY; REBOXETINE;
D O I
10.1016/j.bmcl.2010.11.066
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compounds with combined norepinephrine reuptake inhibitor (NRI) and serotonin 1A (5-HT1A) partial agonist pharmacology may offer a new therapeutic approach for treating symptoms of neuropsychiatric disorders including ADHD, depression, and anxiety. Herein we describe the design and optimization of novel chemical matter that exhibits favorable dual NRI and 5-HT1A partial agonist activity. Lead compounds in this series were found to be devoid of activity at the dopamine transporter and were shown to be brain penetrant with high receptor occupancy. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:865 / 868
页数:4
相关论文
共 50 条
  • [31] ATTENUATION OF OPIOID INDUCED ANTINOCICEPTION BY 5-HT1A PARTIAL AGONISTS IN THE RAT
    MILLAN, MJ
    COLPAERT, FC
    NEUROPHARMACOLOGY, 1990, 29 (03) : 315 - 318
  • [32] Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists
    Chilmonczyk, Z
    Krajewski, KJ
    Cybulski, J
    FARMACO, 2002, 57 (11): : 917 - 923
  • [33] 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)
    Hjorth, S
    Auerbach, SB
    BEHAVIOURAL BRAIN RESEARCH, 1996, 73 (1-2) : 281 - 283
  • [34] Design, Synthesis, and Structure-Activity Relationship Studies of Novel Indolyalkylpiperazine Derivatives as Selective 5-HT1A Receptor Agonists
    Wang, Wenli
    Zheng, Lan
    Li, Wei
    Zhu, Chen
    Peng, Weiqing
    Han, Bing
    Fu, Wei
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (01) : 235 - 248
  • [35] Synthesis and pharmacological evaluation of carboxamide derivatives as selective serotoninergic 5-HT4 receptor agonists
    Itoh, K
    Kanzaki, K
    Ikebe, T
    Kuroita, T
    Tomozane, H
    Sonda, S
    Sato, N
    Haga, K
    Kawakita, T
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (04) : 329 - 341
  • [36] Synthesis and pharmacological evaluation of carboxamide derivatives as selective serotoninergic 5-HT4 receptor agonists
    Itoh, K
    Kanzaki, K
    Ikebe, T
    Kuroita, T
    Tomozane, H
    Sonda, S
    Sato, N
    Haga, K
    Kawakita, T
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (11) : 977 - 989
  • [37] Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist
    Li, Cheryl Shuang-wu
    Zhang, Liming
    Haske, Taraneh
    Dounay, Amy
    Gray, David
    Barta, Nancy
    Brodfuehrer, Joanne
    Lepsy, Christopher
    Campbell, Brian
    AAPS JOURNAL, 2012, 14 (02): : 365 - 376
  • [38] Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist
    Cheryl Shuang-wu Li
    Liming Zhang
    Taraneh Haske
    Amy Dounay
    David Gray
    Nancy Barta
    Joanne Brodfuehrer
    Christopher Lepsy
    Brian Campbell
    The AAPS Journal, 2012, 14 : 365 - 376
  • [39] SYNTHESIS OF METABOLICALLY STABLE ARYLPIPERAZINE 5-HT1A RECEPTOR AGONISTS
    ROMERO, AG
    DARLINGTON, WH
    PIERCEY, MF
    LAHTI, RA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (12) : 1703 - 1706
  • [40] Novel. selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity:: chemistry and pharmacological evaluation of a series of thienopyran derivatives
    Torrado, A
    Lamas, C
    Agejas, J
    Jiménez, A
    Díaz, N
    Gilmore, J
    Boot, J
    Findlay, J
    Hayhurst, L
    Wallace, L
    Broadmore, R
    Tomlinson, R
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (20) : 5277 - 5295